Evaluation of the Breast Cancer Index in patients with HER2+/HR+ breast cancer for risk of late recurrence and potential extended endocrine benefit

Autor:	Ruth O'Regan, Brock Schroeder, Catherine A. Schnabel, Nichole Renee Blatner
Rok vydání:	2015
Předmět:	Oncology Gynecology Cancer Research medicine.medical_specialty business.industry Distant recurrence medicine.disease Breast cancer Internal medicine Late Recurrence Endocrine system Medicine In patient Stage (cooking) business
Zdroj:	Journal of Clinical Oncology. 33:595-595
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2015.33.15_suppl.595
Popis:	595 Background: Hormone-receptor positive (HR+), early stage breast cancer patients (pts) are at risk for late ( > 5 year) distant recurrence (DR) and are now considered for extended (10 year) endo...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ebc41851ba1813ce8c2c6c0792c170a4 https://doi.org/10.1200/jco.2015.33.15_suppl.595 Zobrazit plný text záznamu